← Open Payments lookup

NICOLE BACK: Open Payments

NPI 1134672116 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$709 in 19 payments from 12 companies in 2025. Trend: 2023 $427 · 2024 $539 · 2025 $709

Food & beverage: $709
CompanyPaymentsAmount
GENZYME CORPORATION3$167
AstraZeneca Pharmaceuticals LP1$131
Janssen Biotech, Inc.4$118
Merck Sharp & Dohme LLC2$53
Takeda Pharmaceuticals U.S.A., Inc.2$49
ARRAY BIOPHARMA INC1$30
JAZZ PHARMACEUTICALS INC.1$30
BTG International Inc.1$30
Daiichi Sankyo Inc.1$29
Eisai Inc.1$27

Products named: SARCLISA, ERLEADA, KEYTRUDA, AYVAKIT, DARZALEX, BRAFTOVI, ZIIHERA, VORAXAZE.

Industry payments across IL — which companies pay providers there.